Clinical monitoring and correlates of nephropathy in SIV-infected macaques during high-dose antiretroviral therapy

[1]  William A. Lee,et al.  Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys. , 2009, Molecular pharmaceutics.

[2]  Brigitte E. Sanders-Beer,et al.  A therapeutic SIV DNA vaccine elicits T-cell immune responses, but no sustained control of viremia in SIVmac239-infected rhesus macaques. , 2008, AIDS research and human retroviruses.

[3]  K. Abel,et al.  Chronic Administration of Tenofovir to Rhesus Macaques from Infancy through Adulthood and Pregnancy: Summary of Pharmacokinetics and Biological and Virological Effects , 2008, Antimicrobial Agents and Chemotherapy.

[4]  Michael Monsour,et al.  Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir , 2008, PLoS medicine.

[5]  Nihal Ahmad,et al.  Dose translation from animal to human studies revisited , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  L. Haragsim,et al.  Nephrotoxicity as a complication of antiretroviral therapy. , 2006, Advances in chronic kidney disease.

[7]  H. Izzedine,et al.  Fanconi syndrome associated with didanosine therapy. , 2005, AIDS.

[8]  N. Pedersen,et al.  Biological Effects of Short-Term or Prolonged Administration of 9-[2-(Phosphonomethoxy)Propyl]Adenine (Tenofovir) to Newborn and Infant Rhesus Macaques , 2004, Antimicrobial Agents and Chemotherapy.

[9]  N. Pedersen,et al.  Biological Effects of Short-Term or Prolonged Administration of 9-[2-(Phosphonomethoxy)Propyl]Adenine (Tenofovir) to Newborn and Infant Rhesus Macaques , 2004, Antimicrobial Agents and Chemotherapy.

[10]  S. Baudouin,et al.  Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors. , 2001, AIDS.

[11]  M. Haas,et al.  Acute renal failure in an HIV-positive 50-year-old man. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  N. Pedersen,et al.  Prophylactic and Therapeutic Benefits of Short-Term 9-[2-(R)-(Phosphonomethoxy)Propyl]Adenine (PMPA) Administration to Newborn Macaques following Oral Inoculation with Simian Immunodeficiency Virus with Reduced Susceptibility to PMPA , 2000, Journal of Virology.

[13]  J. Shaw,et al.  Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[14]  V. Gattone,et al.  Rhesus Macaques Infected with Macrophage-Tropic Simian Immunodeficiency Virus (SIVmacR71/17E) Exhibit Extensive Focal Segmental and Global Glomerulosclerosis , 1998, Journal of Virology.

[15]  C. Tian,et al.  SIV-associated nephropathy in rhesus macaques infected with lymphocyte-tropic SIVmac239. , 1998, AIDS research and human retroviruses.

[16]  N. Pedersen,et al.  Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. , 1998, AIDS research and human retroviruses.

[17]  J. Lifson,et al.  Effectiveness of Postinoculation (R)-9-(2-Phosphonylmethoxypropyl)Adenine Treatment for Prevention of Persistent Simian Immunodeficiency Virus SIVmne Infection Depends Critically on Timing of Initiation and Duration of Treatment , 1998, Journal of Virology.

[18]  William A. Lee,et al.  Pharmacokinetics and Bioavailability of the Anti-Human Immunodeficiency Virus Nucleotide Analog 9-[(R)2-(Phosphonomethoxy)Propyl]Adenine (PMPA) in Dogs , 1998, Antimicrobial Agents and Chemotherapy.

[19]  K. E. Follis,et al.  Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques. , 1997, AIDS research and human retroviruses.

[20]  J. Ward,et al.  Focal segmental glomerulosclerosis in primates infected with a simian immunodeficiency virus. , 1997, AIDS research and human retroviruses.

[21]  R. Grant,et al.  Prevention of SIV Infection in Macaques by (R)-9-(2-Phosphonylmethoxypropyl)adenine , 1995, Science.

[22]  L. Brown,et al.  AIDS Research and Therapy BioMed Central Review Microbicides 2008 conference: From discovery to advocacy , 2008 .

[23]  M. Crowther,et al.  Dideoxyinosine-associated nephrotoxicity. , 1993, AIDS.

[24]  M. Zwahlen,et al.  Estimating HIV prevalence in Switzerland. , 1993, AIDS.